" /> Adeno-associated Virus Encoding Anti-CD19/Anti-CD3 Bispecific Diabody VNX-101 - CISMeF





Preferred Label : Adeno-associated Virus Encoding Anti-CD19/Anti-CD3 Bispecific Diabody VNX-101;

NCIt synonyms : AAV Encoding Anti-CD19/Anti-CD3 Bispecific Diabody VNX-101; AAV Encoding Anti-CD19/Anti-CD3 Bispecific T-cell Engager VNX-101; AAV.CD3/CD19; AAV Encoding Anti-CD19/Anti-CD3 Bispecific Diabody GP101 VNX-101;

NCIt definition : An off-the-shelf preparation of adeno-associated virus (AAV) encoding the anti-CD19/anti-CD3 bispecific diabody GP101, with potential immunostimulating and antineoplastic activities. Upon administration, AAV encoding anti-CD19/anti-CD3 bispecific diabody VNX-101 induces the secretion of GP101 by hepatocytes and other cells into the bloodstream. GP101 binds to both the CD3 antigen on T-cells and the CD19 antigen expressed on tumor cells. This results in the cross-linking of T-cells and tumor cells, and induces a cytotoxic T-lymphocyte (CTL) response against CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen overexpressed in B-cell lineage malignancies.;

Molecule name : VNX 101; VNX-101;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.